Adaptive Biotechnologies And Microsoft Launch Virtual ImmuneRACE Study To Inform Novel COVID-19 Diagnostics To Address Unmet Needs In Testing
Adaptive Biotechnologies Corp. announced it has begun enrolling a virtual clinical study, ImmuneRACE, as part of a broader effort it has undertaken with Microsoft Corp. to rapidly map and measure…
Share